Showing results (321-330 of 444) with videos related to

Sort By:
Pageof 45
Journal of Clinical Medicine|April 12, 2025
Management of Atrial Fibrillation in Elderly Patients: A Whole New Ballgame?Iris Parrini, Fabiana Lucà, Carmelo Massimiliano Rao, et al.
Giornale Italiano Di Cardiologia (2006)|March 25, 2025
[Follow-up of patients with acute and chronic heart failure: risk stratification to diversify the pathway]Samuela Carigi, Vittoria Rizzello, Renata De Maria, et al.
Giornale Italiano Di Cardiologia (2006)|February 27, 2020
[ANMCO/AIGO Intersocietary consensus document: Gastroprotection in patients receiving antiplatelet and/or anticoagulant drugs]Maurizio Giuseppe Abrignani, Angelo Zullo, Domenico Gabrielli, et al.
International Journal of Molecular Sciences|September 27, 2025
Long-Term Cardiovascular Toxicity of Immunotherapy: Too Important to IgnoreAndrea Camerini, Alessandro Inno, Maria Laura Canale, et al.
Metabolites|August 25, 2023
Appropriateness of Dyslipidemia Management Strategies in Post-Acute Coronary Syndrome: A 2023 UpdateFabiana Lucà, Fabrizio Oliva, Carmelo Massimiliano Rao, et al.
Giornale Italiano Di Cardiologia (2006)|April 29, 2026
[ANMCO-SICPED consensus document on cardio-oncological transition in childhood cancer survivors]Elena Bennati, Maria Laura Canale, Alice Pozza, et al.
Giornale Italiano Di Cardiologia (2006)|July 26, 2021
[ANMCO Position paper: Reorganization of cardiology in the era of the COVID-19 pandemic]Pasquale Caldarola, Adriano Murrone, Loris Roncon, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|August 26, 2020
Updated clinical evidence and place in therapy of bempedoic acid for hypercholesterolemia: ANMCO position paperFurio Colivicchi, Stefania Angela Di Fusco, Pietro Scicchitano, et al.
Giornale Italiano Di Cardiologia (2006)|July 28, 2025
[Individual's eHealth literacy: an update]Maria Teresa Manes, Simona Giubilato, Maura Francese, et al.
Giornale Italiano Di Cardiologia (2006)|December 12, 2022
[ANMCO Position paper: Evidence and practical indications for the use of low-dose rivaroxaban in stable coronary artery disease and peripheral artery disease]Stefania Angela Di Fusco, Vittoria Rizzello, Pietro Scicchitano, et al.
Pageof 45